Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Actelion Management Re-Shuffle Reflects Continued Activist Pressure

This article was originally published in The Pink Sheet Daily

Executive Summary

Changes include new COO role, new business development chief and spinning off non-core assets.
Advertisement

Related Content

Actelion CEO Seeks To Rebuild Investor Confidence As Pressure Builds On Tracleer
First the Activists, Now The Competition: Actelion Faces Continued Challenges
First the Activists, Now The Competition: Actelion Faces Continued Challenges
InterMune Launches Esbriet in Germany At Better-Than-Expected Price
Activist Shareholder Fails In Bid To Control Actelion
Actelion Punches Back Against Activist Shareholder
Actelion Sweetens Shareholders With Maiden Dividend
Actelion Hedge-Fund Shareholder Urges Sale
Actelion Hedge-Fund Shareholder Urges Sale
Actelion, GSK Scrap Sleep Drug Almorexant

Topics

Advertisement
UsernamePublicRestriction

Register

PS072476

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel